ARNA Discussion Board - Arena Pharmaceuticals to Present New Preclinical Atopic Dermatitis Data for Etrasimod at the Europ - ARNA Discussion Board - InvestorVillage
ARNA Discussion Board
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: ARNA Discussion Board   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  44553 of 45422  at  9/21/2019 8:34:26 PM  by

archimboldo


 In response to msg 44550 by  lettruthringout
view thread

Re: Arena Pharmaceuticals to Present New Preclinical Atopic Dermatitis Data for Etrasimod at the European Society for Dermatologic Research Annual Meeting

  The conclusion part seemed pretty clear to me: "Etrasimod significantly reduced the activation and expansion of immune cells after challenge in the dLN and ear skin. Notably, the dose-dependent reduction of immune cells in ear skin correlated with improvements in disease. This data encourages further study of etrasimod as a novel therapy for AD."


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 17     Views: 371
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
44556 Re: Arena Pharmaceuticals to Present New Preclinical Atopic Dermatitis Data for Etrasimod at the European Society for Dermatologic Research Annual Meeting mikezzz111 8 9/22/2019 12:25:52 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...